跳至主要内容
临床试验/NCT00838149
NCT00838149已完成1 期

Effect of Glutamine Supplementation on the Structure and Function of the Mucosa of Small Intestine in Crohn's Disease: A Randomized Controlled Trial

All India Institute of Medical Sciences, New Delhi2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2005年11月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
30
试验地点
2
主要终点
Improvement in intestinal permeability after glutamine supplementation

研究概览

简要总结

The purpose of this study is to see whether enteral glutamine supplementation improves intestinal permeability and small intestinal morphology in patients with Crohn's disease.

详细描述

Glutamine is the most abundant amino acid in the body constituting 50% to 60% of total free amino acid pool in muscle and 20% in plasma. Recently it has been reclassified as a conditionally essential amino acid due to body's inability to synthesize sufficient amount under stressful conditions like trauma and sepsis. It is an essential fuel for fibroblasts, lymphocytes and enterocytes. It plays an important role in nitrogen balance and an integral role in glucose regulation and also in acid base homeostasis. It is an essential ingredient for glutathione, an important antioxidant. During the last decade a number of experimental and clinical studies, by using enteral and parenteral glutamine supplements, have shown its beneficial role in conditions like sepsis and infection, elective surgery and accidental injury, catabolic state, fetal and critically ill low birth weight neonates and cancer. A few experimental and clinical studies have also shown its positive role in inflammatory bowel disease, which is attributed to the effect of glutamine on intestinal permeability, growth of enterocytes, enhancement of gut immunity and glutathione synthesis. So far there is hardly any well-planned randomized trial of enteral glutamine supplements in Crohn's disease. Hence this study is planned to evaluate effect of enteral glutamine supplements on structure and function of intestine in patients with Crohn's disease.

Diagnosed cases of Crohn's Disease attending Gastroenterology OPD or admitted in ward at AIIMS will be randomized into two groups, glutamine and whey protein group. The parameters for intestinal function and structure tested will be, permeability, villous height, plasma glutamine and D-xylose absorption at the base line and at the end of the intervention. As per the available data improvement is expected in both structure and function of the intestine, which will be an important contribution in the management of this chronic disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 60 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • All the consecutive patients with Crohn's disease in the remission phase with an abnormal intestinal permeability (IP)

排除标准

  • Patients in the active phase of the disease i.e. CDAI score >150
  • Patients with a normal intestinal permeability i.e. LMR < 0.0373
  • Patients already taking a high protein nutritional supplement
  • Patients with other associated systemic diseases like chronic liver disease, chronic kidney disease, diabetes mellitus, malignancy
  • Patients with a special physiologic condition i.e., pregnancy or lactation.
  • Patients lesser than 15 years (pediatric group) and more than 60 years of age (elderly patients)

结局指标

主要结局

Improvement in intestinal permeability after glutamine supplementation

时间窗: Baseline and after two months of intervention

次要结局

  • Change in small intestinal morphology after glutamine supplementation(Baseline and after two months of intervention)

研究者

发起方
All India Institute of Medical Sciences, New Delhi
申办方类型
Other

研究点 (2)

Loading locations...

相似试验